Unlocking pathology archives for molecular genetic studies: A reliable method to generate probes for chromogenic and fluorescent in situ hybridization

Laboratory Investigation

Volumn 86, Issue 4, 2006, Pages 398-408

  Lambros, Maryou B K ^a   Simpson, Pete T ^b   Jones, Chris ^a   Natrajan, Rachael ^a   Westbury, Charlotte ^a   Steele, Dawn ^a   Savage, Kay ^a   Mackay, Alan ^a   Schmitt, Fernando C ^c,d   Ashworth, Alan ^a   Reis Filho, Jorge S ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c UNIVERSITY OF PORTO   (Portugal)

^d University of Porto   (Portugal)

Author keywords

Chromogenic in situ hybridization; Comparative genomic hybridization; Fluorescent in situ hybridization; Molecular pathology; Protocol

Indexed keywords

BIOTIN; CYCLIN D1; DNA FRAGMENT; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FORMALDEHYDE; PARAFFIN;

ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; BREAST CANCER; BREAST CARCINOMA; CHEMICAL LABELING; CHROMOGENIC IN SITU HYBRIDIZATION; CHROMOSOME TRANSLOCATION 12; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA MICROARRAY; ETV6 GENE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE AMPLIFICATION; GENE LOCATION; GENE MAPPING; GENE NUMBER; GENETIC PROCEDURES; HISTOLOGY; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; LYMPHOCYTE; METAPHASE; MOLECULAR GENETICS; MOLECULAR PROBE; NTRK3 GENE; PATHOGENESIS; PLEOMORPHIC ADENOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN FUNCTION; RELIABILITY; SAMPLE; TISSUE SECTION; VALIDATION PROCESS;

ADENOMA, PLEOMORPHIC; BIOLOGICAL SPECIMEN BANKS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CHROMOGENIC COMPOUNDS; CHROMOSOMES, ARTIFICIAL, BACTERIAL; DNA PROBES; FEMALE; HUMANS; IN SITU HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PARAFFIN EMBEDDING; PATHOLOGY; SALIVARY GLAND NEOPLASMS; SENSITIVITY AND SPECIFICITY; TISSUE FIXATION; TRANSLOCATION, GENETIC;

EID: 33645326209     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.3700390     Document Type: Article

References (29)

1. Reis Filho JS, Simpson PT, Gale T, et al. The molecular genetics of breast cancer: the contribution of comparative genomic hybridization. Pathol Res Pract 2005;201: 713-725.
2. Pinkel D, Albertson DG. Array comparative genomic hybridization and its applications in cancer. Nat Genet 2005;37(Suppl):S11-S17.
3. Simpson PT, Reis-Filho JS, Gale T, et al. Molecular evolution of breast cancer. J Pathol 2005;205:248-254.
4. Di Palma S, Lambros MBK, Savage K, et al. Oncocytic metaplasia in pleomorphic adenoma: molecular evidence in support of an origin in neoplastic cells. J Clin Pathol 2005 in press.
5. Hwang ES, DeVries S, Chew KL, et al. Patterns of chromosomal alterations in breast ductal carcinoma in situ. Clin Cancer Res 2004;10:5160-5167.
6. Devries S, Nyante S, Korkola J, et al. Array-based comparative genomic hybridization from formalin-fixed, paraffin-embedded breast tumors. J Mol Diagn 2005;7:65-71.
7. Shelley Hwang E, Nyante SJ, Yi Chen Y, et al. Clonality of lobular carcinoma in situ and synchronous invasive lobular carcinoma. Cancer 2004;100:2562-2572.
8. Wa CV, DeVries S, Chen YY, et al. Clinical application of array-based comparative genomic hybridization to define the relationship between multiple synchronous tumors. Mod Pathol 2005;18:591-597.
9. Reis-Filho JS, Simpson PT, Jones C, et al. Pleomorphic lobular carcinoma of the breast: role of comprehensive molecular pathology in characterization of an entity. J Pathol 2005;207:1-13.
10. Heim S, Teixeira MR, Dietrich CU, et al. Cytogenetic polyclonality in tumors of the breast. Cancer Genet Cytogenet 1997;95:16-19.
11. Pandis N, Teixeira MR, Adeyinka A, et al. Cytogenetic comparison of primary tumors and lymph node metastases in breast cancer patients. Genes Chromosomes Cancer 1998;22:122-129.
12. Going JJ, Abd El-Monem HM, Craft JA. Clonal origins of human breast cancer. J Pathol 2001;194:406-412.
13. Prentice LM, Shadeo A, Lestou VS, et al. NRG1 gene rearrangements in clinical breast cancer: identification of an adjacent novel amplicon associated with poor prognosis. Oncogene 2005;24:7285-7289.
14. Al-Kuraya K, Schraml P, Torhorst J, et al. Prognostic relevance of gene amplifications and coamplifications in breast cancer. Cancer Res 2004;64:8534-8540.
15. Bhargava R, Gerald WL, Li AR, et al. EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations. Mod Pathol 2005;18:1027-1033.
16. Bhargava R, Oppenheimer O, Gerald W, et al. Identification of MYCN gene amplification in neuroblastoma using chromogenic in situ hybridization (CISH): an alternative and practical method. Diagn Mol Pathol 2005;14:72-76.
17. Arnould L, Denoux Y, MacGrogan G, et al. Agreement between chromogenic in situ hybridization (CISH) and FISH in the determination of HER2 status in breast cancer. Br J Cancer 2003;88:1587-1591.
18. Isola J, Tanner M, Forsyth A, et al. Interlaboratory comparison of HER-2 oncogene amplification as detected by chromogenic and fluorescence in situ hybridization. Clin Cancer Res 2004;10:4793-4798.
19. Loring P, Cummins R, O'Grady A, et al. HER2 positivity in breast carcinoma: a comparison of chromogenic in situ hybridization with fluorescence in situ hybridization in tissue microarrays, with targeted evaluation of intratumoral heterogeneity by in situ hybridization. Appl Immunohistochem Mol Morphol 2005;13:194-200.
20. Rook MS, Delach SM, Deyneko G, et al. Whole genome amplification of DNA from laser capture-microdissected tissue for high-throughput single nucleotide polymorphism and short tandem repeat genotyping. Am J Pathol 2004;164:23-33.
21. Lage JM, Leamon JH, Pejovic T, et al. Whole genome analysis of genetic alterations in small DNA samples using hyperbranched strand displacement amplification and array-CGH. Genome Res 2003;13:294-307.
22. Sato M, Ohtsuka M, Ohmi Y. Usefulness of repeated GenomiPhi, a phi29 DNA polymerase-based rolling circle amplification kit, for generation of large amounts of plasmid DNA. Biomol Eng 2005;22:129-132.
23. Evans MF, Aliesky HA, Cooper K. Optimization of biotinyl-tyramide-based in situ hybridization for sensitive background-free applications on formalin-fixed, paraffin-embedded tissue specimens. BMC Clin Pathol 2003;3:2.
24. Yang YH, Dudoit S, Luu P, et al. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucl Acids Res 2002;30:e15-e24.
25. Hupe P, Stransky N, Thiery JP, et al. Analysis of array CGH data: from signal ratio to gain and loss of DNA regions. Bioinformatics 2004;20:3413-3422.
26. Paris PL, Andaya A, Fridlyand J, et al. Whole genome scanning identifies genotypes associated with recurrence and metastasis in prostate tumors. Hum Mol Genet 2004;13:1303-1313.
27. Reis-Filho JS, Milanezi F, Carvalho S, et al. Metaplastic breast carcinomas show EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis. Breast Cancer Res 2005;7:R1028-R1035.
28. Tognon C, Knezevich SR, Huntsman D, et al. Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell 2002;2:367-376.
29. Makretsov N, He M, Hayes M, et al. A fluorescence in situ hybridization study of ETV6-NTRK3 fusion gene in secretory breast carcinoma. Genes Chromosomes Cancer 2004;40:152-157.